 | • レポートコード：QYR9N8070 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、固形腫瘍薬のグローバル市場について調査・分析したレポートで、種類別（小分子、生物製剤）、用途別（病院、診療所、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・固形腫瘍薬の世界市場規模 ・主要企業別市場シェア ・固形腫瘍薬の世界市場規模：種類別（小分子、生物製剤） ・固形腫瘍薬の世界市場規模：用途別（病院、診療所、学術研究機関） ・固形腫瘍薬のアメリカ市場規模（種類別、用途別） ・固形腫瘍薬のヨーロッパ市場規模（種類別、用途別） ・固形腫瘍薬の中国市場規模（種類別、用途別） ・固形腫瘍薬の日本市場規模（種類別、用途別） ・固形腫瘍薬の東南アジア市場規模（種類別、用途別） ・固形腫瘍薬のインド市場規模（種類別、用途別） ・固形腫瘍薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・固形腫瘍薬の世界市場予測（2019年-2025年） ・固形腫瘍薬の地域別市場予測（2019年-2025年） ... |
Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.During 2017, the biologics segment dominated the market and accounted for close to 55% of the market share in terms of revenue. This segment consists of medicinal products extracted from biological sources such as human, animal, microorganisms, or they are manufactured using the latest, cutting-edge biotechnological processes. Biologics include products such as enzymes, blood and blood components, gene therapy, recombinant proteins, somatic cells, tissues, and vaccines.
In terms of geography, the Americas dominated the global solid tumors drugs market. The growth of this market in the Americas is attributed to the increasing uptake of existing biologics drugs and the launch of new biologics. However, the revenue from these drugs will decrease during the forecast period because of the loss of patent exclusivity of drugs, leading to the entry of generics. This decline is expected to be partially offset by favorable reimbursement plans by the government, such as the provision of Medicare and Medicaid. The US is the largest revenue contributor in this region.
In 2018, the global Solid Tumors Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Solid Tumors Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Solid Tumors Drugs development in United States, Europe and China.
The key players covered in this study
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
Eli Lilly
GSK
Merck
Sanofi
AbbVie
AstraZeneca
Bayer
Biogen
Boehringer Ingelheim
Boston Biomedical
Daiichi Sankyo
Market segment by Type, the product can be split into
Small Molecules
Biologics
Market segment by Application, split into
Hospitals
Clinics
Academic and Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Solid Tumors Drugs status, future forecast, growth opportunity, key market and key players.
To present the Solid Tumors Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Solid Tumors Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Solid Tumors Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Small Molecules
1.4.3 Biologics
1.5 Market by Application
1.5.1 Global Solid Tumors Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Solid Tumors Drugs Market Size
2.2 Solid Tumors Drugs Growth Trends by Regions
2.2.1 Solid Tumors Drugs Market Size by Regions (2014-2025)
2.2.2 Solid Tumors Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Solid Tumors Drugs Market Size by Manufacturers
3.1.1 Global Solid Tumors Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Solid Tumors Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Solid Tumors Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Solid Tumors Drugs Key Players Head office and Area Served
3.3 Key Players Solid Tumors Drugs Product/Solution/Service
3.4 Date of Enter into Solid Tumors Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Solid Tumors Drugs Market Size by Type (2014-2019)
4.2 Global Solid Tumors Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Solid Tumors Drugs Market Size (2014-2019)
5.2 Solid Tumors Drugs Key Players in United States
5.3 United States Solid Tumors Drugs Market Size by Type
5.4 United States Solid Tumors Drugs Market Size by Application
6 Europe
6.1 Europe Solid Tumors Drugs Market Size (2014-2019)
6.2 Solid Tumors Drugs Key Players in Europe
6.3 Europe Solid Tumors Drugs Market Size by Type
6.4 Europe Solid Tumors Drugs Market Size by Application
7 China
7.1 China Solid Tumors Drugs Market Size (2014-2019)
7.2 Solid Tumors Drugs Key Players in China
7.3 China Solid Tumors Drugs Market Size by Type
7.4 China Solid Tumors Drugs Market Size by Application
8 Japan
8.1 Japan Solid Tumors Drugs Market Size (2014-2019)
8.2 Solid Tumors Drugs Key Players in Japan
8.3 Japan Solid Tumors Drugs Market Size by Type
8.4 Japan Solid Tumors Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Solid Tumors Drugs Market Size (2014-2019)
9.2 Solid Tumors Drugs Key Players in Southeast Asia
9.3 Southeast Asia Solid Tumors Drugs Market Size by Type
9.4 Southeast Asia Solid Tumors Drugs Market Size by Application
10 India
10.1 India Solid Tumors Drugs Market Size (2014-2019)
10.2 Solid Tumors Drugs Key Players in India
10.3 India Solid Tumors Drugs Market Size by Type
10.4 India Solid Tumors Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Solid Tumors Drugs Market Size (2014-2019)
11.2 Solid Tumors Drugs Key Players in Central & South America
11.3 Central & South America Solid Tumors Drugs Market Size by Type
11.4 Central & South America Solid Tumors Drugs Market Size by Application
12 International Players Profiles
12.1 Hoffmann-La Roche
12.1.1 Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Solid Tumors Drugs Introduction
12.1.4 Hoffmann-La Roche Revenue in Solid Tumors Drugs Business (2014-2019)
12.1.5 Hoffmann-La Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Solid Tumors Drugs Introduction
12.2.4 Novartis Revenue in Solid Tumors Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Solid Tumors Drugs Introduction
12.3.4 Celgene Revenue in Solid Tumors Drugs Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Solid Tumors Drugs Introduction
12.4.4 Johnson & Johnson Revenue in Solid Tumors Drugs Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Solid Tumors Drugs Introduction
12.5.4 Pfizer Revenue in Solid Tumors Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 BMS
12.6.1 BMS Company Details
12.6.2 Company Description and Business Overview
12.6.3 Solid Tumors Drugs Introduction
12.6.4 BMS Revenue in Solid Tumors Drugs Business (2014-2019)
12.6.5 BMS Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Solid Tumors Drugs Introduction
12.7.4 Eli Lilly Revenue in Solid Tumors Drugs Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 GSK
12.8.1 GSK Company Details
12.8.2 Company Description and Business Overview
12.8.3 Solid Tumors Drugs Introduction
12.8.4 GSK Revenue in Solid Tumors Drugs Business (2014-2019)
12.8.5 GSK Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Solid Tumors Drugs Introduction
12.9.4 Merck Revenue in Solid Tumors Drugs Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Solid Tumors Drugs Introduction
12.10.4 Sanofi Revenue in Solid Tumors Drugs Business (2014-2019)
12.10.5 Sanofi Recent Development
12.11 AbbVie
12.12 AstraZeneca
12.13 Bayer
12.14 Biogen
12.15 Boehringer Ingelheim
12.16 Boston Biomedical
12.17 Daiichi Sankyo
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Solid Tumors Drugs Key Market Segments
Table Key Players Solid Tumors Drugs Covered
Table Global Solid Tumors Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Solid Tumors Drugs Market Size Market Share by Type 2014-2025
Figure Small Molecules Figures
Table Key Players of Small Molecules
Figure Biologics Figures
Table Key Players of Biologics
Table Global Solid Tumors Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Academic and Research Institutes Case Studies
Figure Solid Tumors Drugs Report Years Considered
Table Global Solid Tumors Drugs Market Size 2014-2025 (Million US$)
Figure Global Solid Tumors Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Solid Tumors Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Solid Tumors Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Solid Tumors Drugs Market Share by Regions 2014-2019
Figure Global Solid Tumors Drugs Market Share by Regions 2014-2019
Figure Global Solid Tumors Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Solid Tumors Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Solid Tumors Drugs Market Share by Manufacturers (2014-2019)
Figure Global Solid Tumors Drugs Market Share by Manufacturers in 2018
Table Global Solid Tumors Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Solid Tumors Drugs Product/Solution/Service
Table Date of Enter into Solid Tumors Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Solid Tumors Drugs Market Size Share by Type (2014-2019)
Figure Global Solid Tumors Drugs Market Size Market Share by Type (2014-2019)
Table Global Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Solid Tumors Drugs Market Size Share by Application (2014-2019)
Figure Global Solid Tumors Drugs Market Size Market Share by Application (2014-2019)
Figure Global Solid Tumors Drugs Revenue Market Share by Application in 2018
Figure United States Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Solid Tumors Drugs Market Share (2018-2019)
Table United States Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Solid Tumors Drugs Market Share by Type (2014-2019)
Table United States Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Solid Tumors Drugs Market Share by Application (2014-2019)
Figure Europe Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Solid Tumors Drugs Market Share (2018-2019)
Table Europe Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Solid Tumors Drugs Market Share by Type (2014-2019)
Table Europe Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Solid Tumors Drugs Market Share by Application (2014-2019)
Figure China Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Solid Tumors Drugs Market Share (2018-2019)
Table China Solid Tumors Drugs Market Size by Type (2014-20189) (Million US$)
Table China Solid Tumors Drugs Market Share by Type (2014-2019)
Table China Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table China Solid Tumors Drugs Market Share by Application (2014-2019)
Figure Japan Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Solid Tumors Drugs Market Share (2018-2019)
Table Japan Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Solid Tumors Drugs Market Share by Type (2014-2019)
Table Japan Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Solid Tumors Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Solid Tumors Drugs Market Share (2018-2019)
Table Southeast Asia Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Solid Tumors Drugs Market Share by Type (2014-2019)
Table Southeast Asia Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Solid Tumors Drugs Market Share by Application (2014-2019)
Figure India Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Solid Tumors Drugs Market Share (2018-2019)
Table India Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table India Solid Tumors Drugs Market Share by Type (2014-2019)
Table India Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table India Solid Tumors Drugs Market Share by Application (2014-2019)
Figure Central & South America Solid Tumors Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Solid Tumors Drugs Market Share (2018-2019)
Table Central & South America Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Solid Tumors Drugs Market Share by Type (2014-2019)
Table Central & South America Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Solid Tumors Drugs Market Share by Application (2014-2019)
Table Hoffmann-La Roche Company Details
Table Hoffmann-La Roche Revenue in Solid Tumors Drugs Business (2014-2019) (Million US$)
Figure Hoffmann-La Roche Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Novartis Recent Development
Table Celgene Company Details
Table Celgene Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Celgene Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Pfizer Recent Development
Table BMS Company Details
Table BMS Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure BMS Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table BMS Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table GSK Company Details
Table GSK Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table GSK Recent Development
Table Merck Company Details
Table Merck Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
Table Sanofi Recent Development
Table AbbVie Company Details
Table AstraZeneca Company Details
Table Bayer Company Details
Table Biogen Company Details
Table Boehringer Ingelheim Company Details
Table Boston Biomedical Company Details
Table Daiichi Sankyo Company Details
Table Global Solid Tumors Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Solid Tumors Drugs Market Size Share by Regions (2019-2025)
Figure Global Solid Tumors Drugs Market Size Share by Regions in 2025
Figure United States Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Solid Tumors Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Solid Tumors Drugs Market Size by Product (2019-2025)
Figure Global Solid Tumors Drugs Market Size by Product in 2025
Table Global Solid Tumors Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Solid Tumors Drugs Market Size by Application (2019-2025)
Figure Global Solid Tumors Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のテネクテプラーゼ薬市場：市場規模・現状・予測 Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug.It is estimated that North America dominated the …- 世界の凍結乾燥注射薬市場：市場規模・現状・予測 Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period.In 2018, the global Lyophilized Injectable Drugs market size was xx million US$ and it is expected to reach xx million US$ by the …
- 世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 世界の鼻出血薬市場：市場規模・現状・予測 A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils.Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to cr…
- 世界のうつ病薬市場：市場規模・現状・予測 Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease y…